1. LGG-52. BINIMETINIB IN CHILDREN WITH PROGRESSIVE OR RECURRENT LOW-GRADE GLIOMA NOT ASSOCIATED WITH NEUROFIBROMATOSIS TYPE 1: INITIAL RESULTS FROM A MULTI-INSTITUTIONAL PHASE II STUDY. (4th December 2020) Authors: Robison, Nathan; Pauly, Jasmine; Malvar, Jemily; Gardner, Sharon; Allen, Jeffrey; MacDonald, Tobey; Aguilera, Dolly; Baxter, Patricia; Bendel, Anne; Kilburn, Lindsay; Leary, Sarah; Bowers, Daniel; Dorris, Kathleen; Gauvain, Karen; Alva, Elizabeth; Cohen, Kenneth; Nazemi, Kellie; Tan, Yi Juin; Mar... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 3 Page Start: iii376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LTBK-04. LATE BREAKING ABSTRACT: MEK162 (binimetinib) in children with progressive or recurrent low-grade glioma: a multi-institutional phase II and target validation study. (13th June 2022) Authors: Robison, Nathan; Pauly, Jasmine; Malvar, Jemily; Gardner, Sharon; Allen, Jeffrey; Margol, Ashley; MacDonald, Tobey; Bendel, Anne; Kilburn, Lindsay; Cluster, Andrew; Bowers, Daniel; Dorris, Kathleen; Ullrich, Nicole; De Mola, Rebecca Loret; Alva, Elizabeth; Leary, Sarah; Baxter, Patricia; Khatib, ... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗